Robert E. Drolet

2.5k total citations · 1 hit paper
18 papers, 1.7k citations indexed

About

Robert E. Drolet is a scholar working on Neurology, Physiology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Robert E. Drolet has authored 18 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Neurology, 8 papers in Physiology and 5 papers in Cellular and Molecular Neuroscience. Recurrent topics in Robert E. Drolet's work include Parkinson's Disease Mechanisms and Treatments (14 papers), Lysosomal Storage Disorders Research (5 papers) and Nerve injury and regeneration (4 papers). Robert E. Drolet is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (14 papers), Lysosomal Storage Disorders Research (5 papers) and Nerve injury and regeneration (4 papers). Robert E. Drolet collaborates with scholars based in United States, United Kingdom and China. Robert E. Drolet's co-authors include J. Timothy Greenamyre, Jason R. Cannon, Vı́ctor Tapias, Laura Montero, John L. Goudreau, Bahareh Behrouz, Pier G. Mastroberardino, Nathan G. Hatcher, Lihang Yao and Keith J. Lookingland and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Neuroscience and PLoS ONE.

In The Last Decade

Robert E. Drolet

18 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A highly reproducible rotenone model of Parkinson's disease

2009 600 citations Jason R. Cannon, Vı́ctor Tapias et al. Neurobiology of Disease profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robert E. Drolet United States	15	1.0k	639	503	502	336	18	1.7k
Sudhakar Subramaniam United States	11	798 0.8×	477 0.7×	377 0.7×	570 1.1×	422 1.3×	19	1.7k
Vı́ctor Tapias United States	23	862 0.8×	650 1.0×	458 0.9×	693 1.4×	305 0.9×	34	2.2k
Anamitra Ghosh United States	21	811 0.8×	673 1.1×	492 1.0×	1.1k 2.1×	539 1.6×	33	2.4k
Adrien W. Schmid Switzerland	18	815 0.8×	430 0.7×	820 1.6×	835 1.7×	267 0.8×	26	2.0k
Javier Sánchez-Padilla United States	10	995 1.0×	1.0k 1.6×	312 0.6×	865 1.7×	246 0.7×	10	1.9k
Anand Rane United States	21	826 0.8×	647 1.0×	711 1.4×	944 1.9×	416 1.2×	32	2.3k
Hugo Vicente Miranda Portugal	19	657 0.6×	384 0.6×	594 1.2×	465 0.9×	261 0.8×	29	1.5k
Iria Carballo‐Carbajal Spain	13	1.2k 1.2×	738 1.2×	469 0.9×	923 1.8×	375 1.1×	15	2.1k
Slobodanka Vukosavić United States	13	1.5k 1.4×	1.1k 1.8×	521 1.0×	759 1.5×	700 2.1×	19	2.5k
Mustafa T. Ardah United Arab Emirates	19	1.7k 1.7×	655 1.0×	894 1.8×	538 1.1×	337 1.0×	33	2.5k

Countries citing papers authored by Robert E. Drolet

Since Specialization

Citations

This map shows the geographic impact of Robert E. Drolet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert E. Drolet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert E. Drolet more than expected).

Fields of papers citing papers by Robert E. Drolet

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert E. Drolet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert E. Drolet. The network helps show where Robert E. Drolet may publish in the future.

Co-authorship network of co-authors of Robert E. Drolet

This figure shows the co-authorship network connecting the top 25 collaborators of Robert E. Drolet. A scholar is included among the top collaborators of Robert E. Drolet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert E. Drolet. Robert E. Drolet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Vergara, Hernando Martínez, Sean M. Smith, Jacob Marcus, et al.. (2024). Multimodal Blood-Based Biomarker Panel Reveals Altered Lysosomal Ionic Content in Alzheimer’s Disease. ACS Chemical Biology. 20(1). 137–152. 2 indexed citations

Polinski, Nicole K., Terina N. Martinez, A. Gorodinsky, et al.. (2021). Decreased glucocerebrosidase activity and substrate accumulation of glycosphingolipids in a novel GBA1 D409V knock-in mouse model. PLoS ONE. 16(6). e0252325–e0252325. 23 indexed citations

Jinn, Sarah, Lihang Yao, Monika Kandebo, et al.. (2021). A novel glucosylceramide synthase inhibitor attenuates alpha synuclein pathology and lysosomal dysfunction in preclinical models of synucleinopathy. Neurobiology of Disease. 159. 105507–105507. 14 indexed citations

Rocha, Emily M., Briana R. De Miranda, Sandra L. Castro, et al.. (2019). LRRK2 inhibition prevents endolysosomal deficits seen in human Parkinson's disease. Neurobiology of Disease. 134. 104626–104626. 61 indexed citations

Jinn, Sarah, Cornelis Blauwendraat, Dawn Toolan, et al.. (2019). Functionalization of the TMEM175 p.M393T variant as a risk factor for Parkinson disease. Human Molecular Genetics. 28(19). 3244–3254. 59 indexed citations

Jinn, Sarah, Robert E. Drolet, Paige E. Cramer, et al.. (2017). TMEM175 deficiency impairs lysosomal and mitochondrial function and increases α-synuclein aggregation. Proceedings of the National Academy of Sciences. 114(9). 2389–2394. 177 indexed citations

Greshock, Thomas J., John M. Sanders, Robert E. Drolet, et al.. (2016). Potent, selective and orally bioavailable leucine-rich repeat kinase 2 (LRRK2) inhibitors. Bioorganic & Medicinal Chemistry Letters. 26(11). 2631–2635. 15 indexed citations

Usenovic, Marija, Robert E. Drolet, Lihang Yao, et al.. (2015). Internalized Tau Oligomers Cause Neurodegeneration by Inducing Accumulation of Pathogenic Tau in Human Neurons Derived from Induced Pluripotent Stem Cells. Journal of Neuroscience. 35(42). 14234–14250. 179 indexed citations

Villanueva, Ernesto, et al.. (2013). Non‐motor parkinsonian pathology in aging A53T α‐Synuclein mice is associated with progressive synucleinopathy and altered enzymatic function. Journal of Neurochemistry. 128(4). 536–546. 52 indexed citations

10.

Drolet, Robert E., John M. Sanders, & Jonathan Kern. (2011). Leucine-Rich Repeat Kinase 2 (LRRK2) Cellular Biology: A Review of Recent Advances in Identifying Physiological Substrates and Cellular Functions. Journal of Neurogenetics. 25(4). 140–151. 28 indexed citations

11.

Greenamyre, J. Timothy, Jason R. Cannon, Robert E. Drolet, & Pier G. Mastroberardino. (2010). Lessons from the rotenone model of Parkinson's disease. Trends in Pharmacological Sciences. 31(4). 141–142. 112 indexed citations

12.

Cannon, Jason R., et al.. (2009). A highly reproducible rotenone model of Parkinson's disease. Neurobiology of Disease. 34(2). 279–290. 600 indexed citations breakdown →

13.

Drolet, Robert E., Jason R. Cannon, Laura Montero, & J. Timothy Greenamyre. (2009). Chronic rotenone exposure reproduces Parkinson's disease gastrointestinal neuropathology. Neurobiology of Disease. 36(1). 96–102. 190 indexed citations

14.

Drolet, Robert E., et al.. (2008). Effects of Sildenafil on Nigrostriatal Dopamine Neurons in a Murine Model of Parkinson's Disease. Journal of Alzheimer s Disease. 15(1). 97–107. 5 indexed citations

15.

Behrouz, Bahareh, et al.. (2007). Unique responses to mitochondrial complex I inhibition in tuberoinfundibular dopamine neurons may impart resistance to toxic insult. Neuroscience. 147(3). 592–598. 18 indexed citations

16.

Drolet, Robert E., Bahareh Behrouz, Keith J. Lookingland, & John L. Goudreau. (2006). Substrate‐mediated enhancement of phosphorylated tyrosine hydroxylase in nigrostriatal dopamine neurons: evidence for a role of α‐synuclein. Journal of Neurochemistry. 96(4). 950–959. 8 indexed citations

17.

Duka, Tetyana, Milan Rusnak, Robert E. Drolet, et al.. (2006). Alpha‐Synuclein induces hyperphosphorylation of Tau in the MPTP model of Parkinsonism. The FASEB Journal. 20(13). 2302–2312. 94 indexed citations

18.

Drolet, Robert E., Bahareh Behrouz, Keith J. Lookingland, & John L. Goudreau. (2004). Mice Lacking α-Synuclein have an Attenuated Loss of Striatal Dopamine Following Prolonged Chronic MPTP Administration. NeuroToxicology. 25(5). 761–769. 92 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact